Subcutaneous injection of H2 is a novel effective treatment for type 2 diabetes
by Chuang Wang, Fangyan Wang, Haifeng Xu, Jiaming Liu, Keke Jin, Mimi Kong, Qingyi Wang, Xiaolong Zhang, Zhengzheng Zhang, Zhuang Zhang
Abstract:
Aims/introduction: In previous studies H2 administration has clearly shown effectiveness in inhibiting diabetes. Here, we evaluated whether subcutaneous injection of H2 shows enhanced efficacy against type 2 diabetes mellitus (T2DM) induced in mice by a high-fat diet and low dose streptozotocin (STZ) treatment. Material and methods: H2 was injected subcutaneously at a dose of 1ml/mouse/week for four weeks. T2DM associated parameters were then evaluated to determine the effectiveness of subcutaneous H2 administration. Results: The body weight of H2 -treated mice did not change over the course of the experiment. Compared to the untreated control animals, glucose, insulin, low-density lipoprotein (LDL) and triglyceride (TG) levels in serum were significantly lower in treated mice, while high-density lipoprotein cholesterol (HDL) in the serum was significantly higher. Glucose tolerance and insulin sensitivity were both improved in H2 -treated mice. Diabetic nephropathy (DN) analysis showed significant reductions in urine volume, urinary total protein and β2 microglobulin, kidney/body weight ratio and kidney fibrosis associated with subcutaneous injection of H2 . Conclusions: Subcutaneous injection of H2 significantly improves T2DM and DN related outcomes in a mouse model, supporting further consideration of subcutaneous injection as a novel and effective route of clinical H2 administration. This article is protected by copyright. All rights reserved.
Read more:
https://doi.org/10.1111/jdi.12674
Related Articles:
Aim: To analyze the effectiveness and safety of hydrogen inhalation (HI) therapy as an adjunct treatment in Chinese type 2 diabetes mellitus (T2DM) patients in a real-life clinical setting. Methods: This observational, non-interventional, retrospective, double-arm, 6-month clinical study included T2DM…
Aim: To evaluate the real-life effectiveness and safety of Chinese patients with type 2 diabetes mellitus (T2DM) receiving hydrogen inhalation (HI) treatment as a supplementary treatment. Methods: This retrospective, multicenter, observational 6-months clinical study included T2DM patients maintaining HI, visited…
Background and aim: Water plays a pivotal role in the body. Alteration of the fluid balance promotes metabolic disorder, thus leading to the development of various diseases, such as diabetes mellitus (DM). Hydrogen-rich water (HW) is recognized as a novel…
The hydrogen-rich water (HW) has been reported to possess a beneficial role in patients with diabetes. However, a systemic evaluation with an appropriate animal model is necessary to reveal its mechanisms and efficacy. Herein, the protective effects of drinking HW…
Context: The colon houses most of our gut microbiota, which ferments indigestible carbohydrates. The products of fermentation have been proposed to influence the secretion of glucagon-like peptide-1 (GLP-1) and peptide YY (PYY) from the many endocrine cells in the colonic…
Introduction: Electrolyzed hydrogen-rich water (EHW) is known to have suppressive effects on oxidative stress (OS). However, its benefit in type 2 diabetes mellitus (T2DM) remains unclear. This study aimed to investigate the effect of EHW on T2DM. Methods: This was…
0 Comments